Literature DB >> 1386933

Tumoricidal capacities of macrophages photodynamically activated with hematoporphyrin derivative.

N Yamamoto1, J K Hoober, N Yamamoto1, S Yamamoto.   

Abstract

Four days after administration to mice of small amounts (30-600 ng/mouse) of hematoporphyrin derivative (HPD), peritoneal macrophages exhibited a greatly enhanced Fc-receptor mediated phagocytic capacity as assayed by ingestion activity of IgG-coated sheep erythrocytes. Much higher doses (greater than 3000 ng/mouse) did not have this effect. The peritoneal macrophages activated by administration of HPD have tumoricidal capacity for IgG-coated retinoblastoma cells. We then studied in vitro photodynamic activation of macrophages by white and red fluorescent light irradiation of mouse peritoneal cells (mixture of macrophages and B and T lymphocytes) in media containing very low concentrations of HPD. A short (5 s) white fluorescent light exposure (1Wm-2) of peritoneal cells in a medium containing 0.03 ng HPD/mL produced the maximal level of ingestion activity of macrophages. A 15 s red fluorescent light exposure (1Wm-2) of peritoneal cells in a medium containing 0.1 ng HPD/mL produced the maximal level of ingestion activity of macrophages. Thus, photodynamic activation of macrophages with white fluorescent light is more efficient than that with red fluorescent light. This can be explained by the fact that HPD has a large absorption peak at about 364 nm which extends into the visible range, and decreasingly smaller absorption bands at 500, 535, 570 and 630 nm. In vitro photodynamically activated macrophages showed efficient tumoricidal activity regardless of the type (white or red) of light used. These results suggest that a low level of HPD promotes therapeutic immunopotentiation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1386933     DOI: 10.1111/j.1751-1097.1992.tb02153.x

Source DB:  PubMed          Journal:  Photochem Photobiol        ISSN: 0031-8655            Impact factor:   3.421


  10 in total

1.  The impact of macrophage-cancer cell interaction on the efficacy of photodynamic therapy.

Authors:  Mladen Korbelik; Michael R Hamblin
Journal:  Photochem Photobiol Sci       Date:  2015-01-26       Impact factor: 3.982

Review 2.  Combination approaches to potentiate immune response after photodynamic therapy for cancer.

Authors:  Tyler G St Denis; Kanza Aziz; Anam A Waheed; Ying-Ying Huang; Sulbha K Sharma; Pawel Mroz; Michael R Hamblin
Journal:  Photochem Photobiol Sci       Date:  2011-04-09       Impact factor: 3.982

3.  Macrophage-directed immunotherapy as adjuvant to photodynamic therapy of cancer.

Authors:  M Korbelik; V R Naraparaju; N Yamamoto
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

4.  Inhibitory effect of vitamin D-binding protein-derived macrophage activating factor on DMBA-induced hamster cheek pouch carcinogenesis and its derived carcinoma cell line.

Authors:  Yukiyo Toyohara; Susumu Hashitani; Hiromitsu Kishimoto; Kazuma Noguchi; Nobuto Yamamoto; Masahiro Urade
Journal:  Oncol Lett       Date:  2011-05-13       Impact factor: 2.967

Review 5.  Combination of photodynamic therapy and immunomodulation: current status and future trends.

Authors:  Yong-Gang Qiang; Christine M N Yow; Zheng Huang
Journal:  Med Res Rev       Date:  2008-07       Impact factor: 12.944

6.  In vivo and in vitro activation of macrophages with a cyanine photosensitizing dye, platonin.

Authors:  Y Nakagawa; S Homma; I Yamamoto; M Banno; H Nakazato; H Imanaga; N Yamamoto
Journal:  Cancer Immunol Immunother       Date:  1993-08       Impact factor: 6.968

Review 7.  Photodynamic therapy.

Authors:  T J Dougherty; C J Gomer; B W Henderson; G Jori; D Kessel; M Korbelik; J Moan; Q Peng
Journal:  J Natl Cancer Inst       Date:  1998-06-17       Impact factor: 13.506

8.  Vitamin D binding protein-macrophage activating factor (DBP-maf) inhibits angiogenesis and tumor growth in mice.

Authors:  Oliver Kisker; Shinya Onizuka; Christian M Becker; Michael Fannon; Evelyn Flynn; Robert D'Amato; Bruce Zetter; Judah Folkman; Rahul Ray; Narasimha Swamy; Steven Pirie-Shepherd
Journal:  Neoplasia       Date:  2003 Jan-Feb       Impact factor: 5.715

9.  Foscan (mTHPC) photosensitized macrophage activation: enhancement of phagocytosis, nitric oxide release and tumour necrosis factor-alpha-mediated cytolytic activity.

Authors:  S Coutier; L Bezdetnaya; S Marchal; V Melnikova; I Belitchenko; J L Merlin; F Guillemin
Journal:  Br J Cancer       Date:  1999-09       Impact factor: 7.640

10.  Induction of immune cell infiltration into murine SCCVII tumour by photofrin-based photodynamic therapy.

Authors:  G Krosl; M Korbelik; G J Dougherty
Journal:  Br J Cancer       Date:  1995-03       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.